Pentoxifylline inhibits granzyme B and perforin expression following T-lymphocyte activation by anti-CD3 antibody

International Journal of Immunopharmacology

Volumn 18, Issue 11, 1996, Pages 623-631

  Hoskin, David W ^a   Phu, Tommy ^a   Makrigiannis, Andrew P ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Fas ligand; Granzyme B; Killer lymphocyte; Pentoxifylline; Perforin

Indexed keywords

FAS ANTIGEN; GRANZYME B; METHYLXANTHINE DERIVATIVE; OKT 3; PENTOXIFYLLINE; PERFORIN;

ANIMAL CELL; ARTICLE; CELL ADHESION; CONTROLLED STUDY; GENE EXPRESSION; IN VITRO STUDY; KILLER CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; TUMOR CELL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD3; CELL DIVISION; CELLS, CULTURED; DEPRESSION, CHEMICAL; GRANZYMES; KILLER CELLS, LYMPHOKINE-ACTIVATED; LYMPHOCYTE ACTIVATION; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; PENTOXIFYLLINE; POLYMERASE CHAIN REACTION; PORE FORMING CYTOTOXIC PROTEINS; SERINE ENDOPEPTIDASES; SPLEEN; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 0030292058     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(96)00069-0     Document Type: Article

References (39)

1. Alegre, M. -L., Gastaldello, K., Abramowicz, D., Kinnaert, P., Vereerstraten, P., De Pauw, L., Vandenabeele, P., Moser, M., Leo, O. & Goldman, M. (1991) Evidence that pentoxifylline reduces anti-CD3 monoclonal antibody-induced cytokine release syndrome. Transplantation, 52, 674-679.
2. + cytotoxic T lymphocyte clones. Eur. J. Immun., 25, 3381-3387.
3. Arase, H., Arase, N. & Saito, T. (1995) Fas-mediated cytotoxicity by freshly isolated natural killer cells. J. Exp. Med., 181, 1235-1238.
4. Betz, M. & Fox. B. S. (1991) Prostaglandin E2 inhibits production of Th1 lymphokines but not Th2 lymphokines. J. Immun., 146, 108-113.
5. Bianco, J. A., Appelbaum, F. R., Nemunaitis, J., Almgren, J., Andrews, F., Kettner, P., Shields, A. & Singer, J. W. (1991) Phase I-II trial of pentoxifylline for the prevention of transplant-related toxicities following bone marrow transplantation. Blood, 78, 1205-1211.
6. Biswas, D. K., Dezube, B. J., Ahlers, C. M. & Pardee, A. B. (1993) Pentoxifylline inhibits HIV-1 LTR-driven gene expression by blocking NFκB action. J. AIDS, 6, 778-786.
7. Fitzpatrick, L., Kaiser, M., Stewart, B. H. & Hoskin, D. W. (1994) Effect of interferon-γ, interleukin-2 and interleukin-4 on cyclosporin-A-mediated inhibition of anti-CD3-induced T-lymphocyte proliferation. Int. J. Immunopharmacol., 16, 289-293.
8. Fitzpatrick, L., Makrigiannis, A. P., Kaiser, M., Hoskin, D. W. (1996) Anti-CD3-activated killer T cells: Interferon-γ and interleukin-10 cross-regulate granzyme B expression and the induction of major histocompatibility complex-unrestricted cytotoxicity. J. Interferon Cyto. Res., 16, 539-548.
9. Funk, J. O., Ernst, M., Schonharting, M. M. & Zabel, P. (1995) Pentoxifylline exerts syngergistic immunomodulatory effects in combination with dexamethasone or cyclosporin A. Int. J. Immunopharmacol., 17, 1007-1016.
10. Kaiser, M., Brooks-Kaiser, J., Fitzpatrick, L., Bleackley, R. C., Hoskin, D. W. (1993) Cytotoxic cell proteinase gene expression and cytolytic activity by anti-CD3-activated cytotoxic T lymphocytes is sensitive to cyclosporin A but is not dependent on IL-2 synthesis. J. Leukoc. Biol., 54, 458-464.
11. Kovach, N. L., Lindgren, C. G., Fefer, A., Thompson, J. A., Yednock, T., Harlan, J. M. (1994) Pentoxifylline inhibits integrin-mediated adherence of interleukin-2-activated human peripheral blood lymphocytes to human umbilical vein endothelial cells, matrix components, and cultured tumor cells. Blood, 84, 2234-2242.
12. Legros-Maida, S., Soulie, A., Benvenuti, C., Wargnier, A., Vallee, N., Berthou, C., Guillet, J., Sasportes, M. & Sigaux, N. (1994) Granzyme B and perforin can be used as predictive markers of acute rejection in heart transplantation. Eur. J. Immun., 24, 229-233.
13. Lipman, M. L., Stevens, A. C. & Strom, T. B. (1994) Heightened intragraft CTL gene expression in acutely rejecting renal allografts. J. Immun., 152, 5120-5127.
14. Leo, O., Foo, M., Sachs, D. H., Samelson, L. E. & Bluestone, J. A. (1987) Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. natn. Acad. Sci. U.S.A., 84, 1374-1378.
15. Lui, C. -C., Joag, S. V., Kwon, B. S. & Young, J. D. -E. (1990) Induction of perforin and serine esterases in a murine cytotoxic T lymphocyte clone. J. Immun., 144, 1196-1201.
16. Maraskovsky, E., Chen, W. -F. & Shortman, K. (1989) IL-2 and IFN-γ are two necessary lymphokines in the development of cytolytic T cells. J. Immun., 143, 1210-1214.
17. McDonald, R. J. (1991) Pentoxifylline reduces injury to isolated lungs perfused with human neutrophils. Am. Rev. Respir. Dis., 144, 1347-1350.
18. H2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immun., 7, 145-173.
19. Nakajima, F., Khanna, A., Xu, G., Lagman, M., Haschemeyer, R., Mouradian, J., Wang, J. C., Stenzel, K. H., Rubin, A. L. & Suthanthiran, M. (1994) Immunotherapy with anti-CD3 monoclonal antibodies and recombinant interleukin 2: stimulation of molecular programs of cytotoxic killer cells and induction of tumor regression. Proc. natn. Acad. Sci. U.S.A., 91, 7889-7893.
20. Novak, T. J. & Rothenberg, E. V. (1990) cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells. Proc. natn. Acad. Sci. U.S.A., 87, 9353-9357.
21. Pober, J. S., LaPierre, L. A., Stolpen, A. H., Brock, T. A., Springer, T. A., Fiers, W., Bevilacqua, M. P., Mendrick, D. L., Gimbrone, M. A. Jr. (1987) Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin 1 species. J. Immun., 138, 3319-3324.
22. Podack, E. R. (1995) Functional significance of two cytolytic pathways of cytotoxic T lymphocytes. J. Leukoc. Biol., 57, 548-552.
23. Poe, M., Blake, J. T., Boulton, D. A., Gammon, M., Sigal, N. H., Wu, J. K. & Zweerink, H. J. (1991) Human cytotoxic lymphocyte granzyme B: its purification from granules and the characterization of substrate and inhibitor specificity. J. Biol. Chem., 266, 98-103.
24. Prendergast, J. A., Helgason, C. D. & Bleackley, C. R. (1992) Qualitative polymerase chain reaction analysis of cytotoxic cell proteinase gene transcripts in T cells. Pattern of expression is dependent on the nature of the stimulus. J. Biol. Chem., 267, 5090-5095.
25. Reed, W. R. & DeGowin, R. L. (1992) Suppressive effects of pentoxifylline on natural killer cell activity. J. Lab. Clin. Med., 119, 763-771.
26. Rieneck, K., Diamant, M., Haahr, P. -M., Schonharting, M. & Bendtzen, K. (1993) In vitro immunomodulatory effects of pentoxifylline. Immun. Lett., 37, 131-138.
27. Robinet, E., Branellec, D., Termijtelen, A. M., Blay, J. Y., Gay, F. & Chouaib, S. (1990) Evidence for tumor necrosis factor-α involvement in the optimal induction of class I allospecific cytotoxic T cells. J. Immun., 144, 4555-4561.
28. Rott, O., Cash, E., Fleischer, B. (1993) Phosphodiesterase inhibitor pentoxifylline, a selective suppressor of T helper type 1-but not type 2-associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis rats. Eur. J. Immun., 23, 1745-1751.
29. Semmler, J., Gebert, U., Eisenhut, T., Moeller, J., Schonharting, M. M., Allera, A. & Endres, S. (1993) Xanthine derivatives: comparison between suppression of tumour necrosis factor-α production and inhibition of cAMP phosphodiesterase activity. Immunology, 78, 520-525.
30. Singer-Sam, J., Robinson, M. O., BellvJ, A. R., Simon, M. I. & Riggs. A. D. (1990) Measurement by quantitative PCR of changes in HPRT, PGK-1, PGK-2, APRT, Mtase, and Zfy gene transcripts during mouse spermatogenesis. Nucl. Acids Res., 18, 1255-1259.
31. Stankova, J., Hoskin, D. W. & Roder, J. C. (1989) Murine anti-CD3 monoclonal antibody induces potent cytolytic activity in both T and NK cell populations. Cell. Immun., 121, 13-29.
32. Suda, T., Okazaki, T., Naito, Y., Yokota, T., Arai, N., Ozaki, S., Nakao, K. & Nagata, S. (1995) Expression of the Fas ligand in cells of T cell lineage. J. Immun., 154, 3806-3813.
33. Takahashi, T., Tanaka, M., Inazawa, J., Abe, T., Suda, T. & Nagata, S. (1994) Human Fas ligand: gene structure, chromosomal location and species specificity. Int. Immun., 6, 1567-1574.
34. Thompson, J. A., Bianco, J. A., Benyunes, M. C., Neubauer, M. A., Slattery, J. T. & Fefer, A. (1994) Phase Ib trial of pentoxifylline and ciprofloxacin in patients treated with interleukin-2 and lymphokine-activated killer cell therapy for metastatic renal cell carcinoma. Cancer Res., 54, 3436-3441.
35. Tilg, H., Eibl, B., Pichl, M., Gachter, A., Herold, M., Brankova, J., Huber, C. & Niederwieser, D. (1993) Immune response modulation by pentoxifylline in vitro. Transplantation, 56, 196-201.
36. Wrenshall, L. E., Carlson, A., Cerra, F. B. & Platt, J. L. (1994) Modulation of cytolytic T cell responses by heparan sulfate. Transplantation, 57, 1087-1094.
37. Ward, A. & Clissold, S. P. (1987) Pentoxifylline: a review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs, 34, 50-97.
38. Weiss, J. M., Vanscheidt, W., Pilarski, K. A., Weyl, A., Peschen, M., Schopf, E., Vestweber, D. & Simon, J. C. (1995) Pentoxifylline inhibits tumor necrosis factor-α (TNF-α)-induced T-lymphoma cell adhesion to endothelioma cells. J. Invest. Dermatol., 104, 824-828.
39. Zabel, P., Schonharting, M. M., Walter, D. T. & Schade, F. U. (1989) Oxpentifylline in endotoxaemia. Lancet, 2, 1474-1477.